Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Conmed Corp before investing.

In this article, we go over a few key elements for understanding Conmed Corp’s stock price such as:

• Conmed Corp’s current stock price and volume
• Why Conmed Corp’s stock price changed recently
• Upgrades and downgrades for CNMD from analysts
• CNMD’s stock price momentum as measured by its relative strength

About Conmed Corp (CNMD)

Before we jump into Conmed Corp’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Want to learn more about Conmed Corp’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Conmed Corp.

Conmed Corp’s Stock Price as of Market Close

As of September 13, 2024, 4:00 PM, CST, Conmed Corp’s stock price was $75.40.

Conmed Corp is down 1.98% from its previous closing price of $76.92.

During the last market session, Conmed Corp’s stock traded between $73.39 and $77.68. Currently, there are 30.81 million shares of Conmed Corp stock available for purchase.

Conmed Corp’s price-earnings (P/E) ratio is currently at 24.4, which is low compared to the Medical Equipment, Supplies & Distribution industry median of 42.3. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Conmed Corp Stock Price History

Conmed Corp’s (CNMD) price is currently up 2.98% so far this month.

During the month of September, Conmed Corp’s stock price has reached a high of $78.19 and a low of $70.09.

Over the last year, Conmed Corp has hit prices as high as $117.27 and as low as $61.05. Year to date, Conmed Corp’s stock is down 14.94%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Conmed Corp Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 12, 2024, there were 8 analysts who downgraded Conmed Corp’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Conmed Corp’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Conmed Corp’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Conmed Corp’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Conmed Corp (CNMD) by visiting AAII Stock Evaluator.

Relative Price Strength of Conmed Corp

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 12, 2024, Conmed Corp has a weighted four-quarter relative price strength of -9.01%, which translates to a Momentum Score of 34 and is considered to be Weak.

Want to learn more about how Conmed Corp is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Conmed Corp Stock Price: Bottom Line

As of September 13, 2024, Conmed Corp’s stock price is $75.40, which is down 1.98% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Conmed Corp stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.